To clarify the impact of BRAF and SPOP mutations on prostate cancer patients’ survival time, the Sangerbox data platform (http://sangerbox.com/home.html) was used to download the mRNA expression matrix and clinical survival data of prostate cancer samples. This evidence concerns the gene BRAF and prostate carcinoma.